Celldex Therapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q3 and 2024-Q4. According to the most recent SEC 13F filing, 7 superinvestors own shares of Celldex Therapeutics Inc (CLDX), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Celldex Therapeutics Inc (CLDX), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Celldex Therapeutics Inc (CLDX) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Celldex Therapeutics Inc (CLDX) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
Superinvestor | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
Gerardo Martinez@Mirador Capital Partners Lp
| 0.55% | $3.02M 119,492 shares@ 25.28 avg price | Increased 2.88% |
Mike Muhizi@Sg Americas Securities, Llc
| 0.01% | $639,000 25,283 shares@ 25.28 avg price | Increased 24.45% |
Richard M. Dolson@Nisa Investment Advisors, Llc
| 0.01% | $13,747 544 shares@ 25.28 avg price | Decreased -20.23% |
Erkko Etula@Brooklyn Investment Group
| 0.01% | $2,477 98 shares@ 25.28 avg price | New Position |
Stephanie Kelm@Rise Advisors, Llc
| 0.01% | $2,097 83 shares@ 25.27 avg price | |
Michael Schremser@Tsfg, Llc
| 0.01% | $1,000 50 shares@ 20.0 avg price | |
Lorraine Wang@Gamma Investing Llc
| 0.01% | $1,112 44 shares@ 25.28 avg price | Decreased -13.72% |